7 Results

People

  1. Drilon
    Drilon
  2. Bale
    Bale
  3. Benayed
    Benayed
  4. Bromberg
    Bromberg
  5. Chandarlapaty
    Chandarlapaty
  6. Chang
    Chang
  7. Gilheeney
    Gilheeney
  8. Halpenny
    Halpenny
  9. Hechtman
    Hechtman
  10. Hyman
    Hyman

Groups

  1. Department of Medicine (3)
  2. Solid Tumor Oncology Division (3)
  3. Thoracic Oncology (3)
  4. Sloan Kettering Institute Postdocs (2)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  6. Body Imaging Service (1)
  7. Breast Medicine Service (1)
  8. Early Drug Development Service (1)
  9. GSK Faculty (1)
  10. Gynecologic Medicine Service (1)
  1. "anaplastic lymphoma kinase"
  2. "2020"
Formats
  1. Journal Article (5)
  2. Guidelines (1)
  3. Review (1)
Groups
  1. Department of Medicine (3)
  2. Solid Tumor Oncology Division (3)
  3. Thoracic Oncology (3)
  4. Sloan Kettering Institute Postdocs (2)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  6. Body Imaging Service (1)

More Groups

People
  1. Alexander Drilon (2)
  2. Ryma Benayed (2)
  3. Adam Schoenfeld (1)
  4. Ahmet Zehir (1)
  5. Aimee-Lauren Rosales (1)
  6. Alison Schram (1)

More People

Years
  1. 2020 (7)
Publications
  1. Advances in Therapy (1)
  2. Annals of Oncology (1)
  3. Cancer Cell (1)
  4. Clinical Lung Cancer (1)
  5. International Journal of Molecular Sciences (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (2)
  2. Cell Press (1)
  3. MDPI (1)
  4. Oxford University Press (1)
  5. Springer (1)
  6. W.B. Saunders Co-Elsevier Inc. (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of stereotactic biopsy in brain metastases
    Review

    Yu, K. K. H.; Patel, A. R.; Moss, N. S.
    Neurosurgery Clinics of North America (2020)

    Fulltext@MSK | Save
  • Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
    Journal Article

    Ross, D. S.; Liu, B.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Unproductive effects of ALK gene amplification and copy number gain in non-small-cell lung cancer. ALK gene amplification and copy gain in NSCLC
    Journal Article

    Marino, F. Z.; Botti, G.; Aquino, G.; Ferrero, S.; Gaudioso, G.; Palleschi, A.; Rocco, D.; Salvi, R.; Micheli, M. C.; Micheli, P.; more...
    International Journal of Molecular Sciences (2020)

    Fulltext@MSK | Save
  • Consensus recommendations for management and counseling of adverse events associated with lorlatinib: A guide for healthcare practitioners
    Guidelines

    Reed, M.; Rosales, A. L. S.; Chioda, M. D.; Parker, L.; Devgan, G.; Kettle, J.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas
    Journal Article

    Ryall, S.; Zapotocky, M.; Fukuoka, K.; Nobre, L.; Guerreiro Stucklin, A.; Bennett, J.; Siddaway, R.; Li, C.; Pajovic, S.; Arnoldo, A.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • Complete pathological response to crizotinib in a patient with ALK-rearranged lung adenocarcinoma
    Journal Article

    Mattar, M. S.; Chang, J.; Benayed, R.; Halpenny, D.; Powers, A.; Kleiner, D. E.; Drilon, A.; Kris, M. G.
    Clinical Lung Cancer (2020)

    Fulltext@MSK | Save
  • Efficacy of platinum/pemetrexed combination chemotherapy in ALK-positive NSCLC refractory to second-generation ALK inhibitors
    Journal Article

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S. R.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save